Drug
Patiromer For
Patiromer For: highest development phase Phase 3, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Patiromer Powder for Oral Suspension (Part A) NCT05136664 | Phase 3 | Hyperkalemia |
Latest
No recent events.
Follow Patiromer For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.